These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 19797171
21. Protein tyrosine phosphatase 1B regulates endothelial endoplasmic reticulum stress; role in endothelial dysfunction. Thiebaut PA, Delile E, Coquerel D, Brunel JM, Renet S, Tamion F, Richard V. Vascul Pharmacol; 2018 Oct; 109():36-44. PubMed ID: 29894845 [Abstract] [Full Text] [Related]
22. Reduced Insulin Resistance Contributes to the Beneficial Effect of Protein Tyrosine Phosphatase-1B Deletion in a Mouse Model of Sepsis. Delile E, Nevière R, Thiébaut PA, Maupoint J, Mulder P, Coquerel D, Renet S, Rieusset J, Richard V, Tamion F. Shock; 2017 Sep; 48(3):355-363. PubMed ID: 28272165 [Abstract] [Full Text] [Related]
23. Leptin Signaling in the Arcuate Nucleus Reduces Insulin's Capacity to Suppress Hepatic Glucose Production in Obese Mice. Balland E, Chen W, Dodd GT, Conductier G, Coppari R, Tiganis T, Cowley MA. Cell Rep; 2019 Jan 08; 26(2):346-355.e3. PubMed ID: 30625317 [Abstract] [Full Text] [Related]
24. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Tack CJ, Ong MK, Lutterman JA, Smits P. Diabetologia; 1998 May 08; 41(5):569-76. PubMed ID: 9628275 [Abstract] [Full Text] [Related]
26. Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis. Owen C, Czopek A, Agouni A, Grant L, Judson R, Lees EK, Mcilroy GD, Göransson O, Welch A, Bence KK, Kahn BB, Neel BG, Mody N, Delibegović M. PLoS One; 2012 May 08; 7(2):e32700. PubMed ID: 22389718 [Abstract] [Full Text] [Related]
27. Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice. Huby AC, Otvos L, Belin de Chantemèle EJ. Hypertension; 2016 May 08; 67(5):1020-8. PubMed ID: 26953321 [Abstract] [Full Text] [Related]
28. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B. Gomez E, Vercauteren M, Kurtz B, Ouvrard-Pascaud A, Mulder P, Henry JP, Besnier M, Waget A, Hooft Van Huijsduijnen R, Tremblay ML, Burcelin R, Thuillez C, Richard V. J Mol Cell Cardiol; 2012 Jun 08; 52(6):1257-64. PubMed ID: 22446161 [Abstract] [Full Text] [Related]
31. WNT5A-JNK regulation of vascular insulin resistance in human obesity. Farb MG, Karki S, Park SY, Saggese SM, Carmine B, Hess DT, Apovian C, Fetterman JL, Bretón-Romero R, Hamburg NM, Fuster JJ, Zuriaga MA, Walsh K, Gokce N. Vasc Med; 2016 Dec 08; 21(6):489-496. PubMed ID: 27688298 [Abstract] [Full Text] [Related]
32. The LIM domain only 4 protein is a metabolic responsive inhibitor of protein tyrosine phosphatase 1B that controls hypothalamic leptin signaling. Pandey NR, Zhou X, Qin Z, Zaman T, Gomez-Smith M, Keyhanian K, Anisman H, Brunel JM, Stewart AF, Chen HH. J Neurosci; 2013 Jul 31; 33(31):12647-55. PubMed ID: 23904601 [Abstract] [Full Text] [Related]
40. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice. Ito Y, Fukui M, Kanda M, Morishita K, Shoji Y, Kitao T, Hinoi E, Shirahase H. J Pharmacol Sci; 2018 May 31; 137(1):38-46. PubMed ID: 29731242 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]